Report: Generics could have saved Medicaid $271M last year

07/22/2010 | Hill, The

An American Enterprise Institute study found that Medicaid is wasting hundreds of millions of dollars each year purchasing name-brand drugs instead of lower-cost generics. "Rising pharmaceutical costs, the aging population and increased use of costly specialty drugs makes containing drug-related spending an urgent health system priority closely linked to expanding access to care and improving quality," said National Coalition on Health Care President and CEO Ralph Neas.

View Full Article in:

Hill, The